Highlights
NASDAQ: MDGL       Madrigal Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
97.53   -6.01 (5.80%)  96.50 - 103.84  202,600

Overview

 
Avg Volume (4 weeks):187,336
4 Weeks Range:89.83 - 107.45
4 Weeks Price Volatility (%):
43.70%
52 Weeks Range:89.83 - 315.00
52 Weeks Price Volatility (%):
3.42%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Geographically, all the business activity is functioned through the US.

  Be the first to like this.
 


 

3253  4640  695  189 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LGCY 0.15+0.012 
 EEM 41.10-0.46 
 AMD 30.36-1.03 
 CUZ 9.74+0.13 
 SPY 289.26-0.32 
 CHK 1.77-0.06 
 GDX 23.33+0.09 
 BAC 28.04+0.10 
 EFA 65.16-0.48 
 EWZ 42.24-0.97 
Partners & Brokers